Published in Gene Therapy Weekly, June 28th, 2001
An important concern facing implementation of gene therapy protocols in humans is the potential of adenovirus infection of oocytes which could pass along potentially unwanted genetic alterations to future generations. J.W. Gordon, Mt. Sinai School of Medicine, New York City, assessed this risk in female mouse germ-line cells and reported the findings in Molecular Therapy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.